Here are three stocks with buy rank and strong value characteristics for investors to consider today, May 9th: Brenntag SE BNTGY: This distributor of chemicals and ingredients carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.1% over the last 60 days. Brenntag AG Price and ConsensusBrenntag AG Price and Consensus Brenntag AG price-consensus-chart | Brenntag AG Quote Brenntag has a price-to-earnings ratio (P/E) of 12.78, compared with 21.56 for the S&P 500. The company possesses a Value Score of A. Brenntag AG PE Ratio (TTM)Brenntag AG PE Ratio (TTM) Brenntag AG pe-ratio-ttm | Brenntag AG Quote Sumitomo Corporation SSUMY: This general trading company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.9% over the last 60 days. Sumitomo Corp. Price and ConsensusSumitomo Corp. Price and Consensus Sumitomo Corp. price-consensus-chart | Sumitomo Corp. Quote Sumitomo has a price-to-earnings ratio (P/E) of 8.45, compared with 13.50 for the industry. The company possesses a Value Score of A. Sumitomo Corp. PE Ratio (TTM)Sumitomo Corp. PE Ratio (TTM) Sumitomo Corp. pe-ratio-ttm | Sumitomo Corp. Quote Fresenius Medical Care AG FMS: This dialysis and related services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days. Fresenius Medical Care AG & Co. KGaA Price and ConsensusFresenius Medical Care AG & Co. KGaA Price and Consensus Fresenius Medical Care AG & Co. KGaA price-consensus-chart | Fresenius Medical Care AG & Co. KGaA Quote Fresenius has a price-to-earnings ratio (P/E) of 13.47, compared with 21.56 for the S&P 500. The company possesses a Value Score of B. Fresenius Medical Care AG & Co. KGaA PE Ratio (TTM)Fresenius Medical Care AG & Co. KGaA PE Ratio (TTM) Fresenius Medical Care AG & Co. KGaA pe-ratio-ttm | Fresenius Medical Care AG & Co. KGaA Quote See the full list of top ranked stocks here. Learn more about the Value score and how it is calculated here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Fresenius Medical Care AG & Co. KGaA (FMS):Free Stock Analysis Report Sumitomo Corp. (SSUMY):Free Stock Analysis Report Brenntag AG (BNTGY):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Best Value Stocks to Buy for May 9th
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...